Drug information for SOLARAZE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
GEL; TOPICAL 3% Prescription  (Reference Drug) DICLOFENAC SODIUM Diclofenac FOUGERA PHARMS 21005
2011-12-14 Letter

2011-12-14 Label

2007-06-07 Letter

2004-07-28 Letter

2004-03-24 Letter

2003-07-08 Review

2003-05-29 Label

2003-05-29 Letter

2000-10-16 Letter

2000-10-16 Label

Drug Adverse Effects information for SOLARAZE

Role code Indications Reaction # Reports
C BLOOD PRESSURE DYSPNOEA 1
C BLOOD PRESSURE HYPERTENSION 1
C HYPERLIPIDAEMIA CEREBRAL VENOUS THROMBOSIS 1
C HYPERLIPIDAEMIA DEEP VEIN THROMBOSIS 1
C HYPERLIPIDAEMIA INJURY 1
C HYPERLIPIDAEMIA PAIN 1
C HYPERTENSION CEREBRAL VENOUS THROMBOSIS 1
C HYPERTENSION DEEP VEIN THROMBOSIS 1
C HYPERTENSION INJURY 1
C HYPERTENSION PAIN 1
C OSTEOARTHRITIS DYSPNOEA 1
C OSTEOARTHRITIS HYPERTENSION 1
C PREMENSTRUAL SYNDROME CEREBRAL VENOUS THROMBOSIS 4
C PREMENSTRUAL SYNDROME DEEP VEIN THROMBOSIS 4
C PREMENSTRUAL SYNDROME INJURY 4
C PREMENSTRUAL SYNDROME PAIN 4
Ads by Google